Targocil
Targocil functions as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis which can inhibit the growth of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) with MIC90s of 2 μg/ mL for both MRSA and MSSA.
Product Specifications
CAS Number
[1200443-21-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Targocil.html
Purity
99.32
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
COC1=CC2=C(C=C1OC)C(N(CC)CC)=NC3=C(S(=O)(C4=CC=C(Cl)C=C4)=O)N=NN32
Molecular Formula
C21H22ClN5O4S
Molecular Weight
475.95
Precautions
H302, H315, H319, H335
References & Citations
[1]Suzuki T, et al. In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2011 Feb;55 (2) :767-74.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
043385-ML650 100 µL
TSPY, CT (TSPY1, TSPY, Testis-specific Y-encoded protein 1, Cancer/testis antigen 78) (MaxLight 650) discontinued
Ask
View Details 